Skip to content

SUPFOR breast milk study: a randomised controlled trial in preterm infants receiving expressed breast milk comparing the use of breast milk fortification versus supplementation using a preterm formula

SUPFOR breast milk study: a randomised controlled trial in preterm infants receiving expressed breast milk comparing the use of breast milk fortification versus SUPplementation using a preterm FORmula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN92790284
Enrollment
100
Registered
2007-07-04
Start date
2006-04-01
Completion date
Unknown
Last updated
2017-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutrition in preterm infants Nutritional, Metabolic, Endocrine Preterm nutrition

Interventions

Groups are minimised on: 1. Growth retarded less than 10 cm 2. Multiple pregnancy 3. Gestation greater than 31 weeks Interventions: Formula supplement (control): 50% of total enteral feeds are prov

Sponsors

Newcastle Hospitals NHS Trust (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Preterm infants (less than 35 weeks gestation) 2. Receiving maternal breast milk

Exclusion criteria

Exclusion criteria: Infants who have already received fortification or supplementation (except where this was used in place of inadequate breast milk supply).

Design outcomes

Primary

MeasureTime frame
1. Weight gain (g/day) during initial hospital stay, measured three times a week 2. Length gain (mm/week) and head growth (mm/week) during initial hospital stay, measured once a week 3. Duration and amount of breast milk provided, measured daily

Secondary

MeasureTime frame
1. Maternal satisfaction, measured weekly and then at discharge 2. Incidence of abnormal biochemistry, measured when samples are taken - usually once a week

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026